Milestone Pharmaceuticals Receives Nasdaq Noncompliance Notice Over Minimum Bid Price
Bitget2026/10/28 21:23- Milestone Pharmaceuticals received a Nasdaq noncompliance notice October 23, 2026, following 30 consecutive business days below the $1 minimum bid price.
- The 180-day compliance period ends April 21, 2027; regaining compliance requires closing bids of at least $1 for 10 consecutive business days.
- The notice has no immediate impact on the common shares’ Nasdaq Global Select Market listing.
- A transfer to the Nasdaq Capital Market could provide additional compliance time, subject to eligibility; a reverse stock split remains an option.
- Failure to regain compliance within the allotted periods would trigger a delisting notice, which could be appealed to a Hearings Panel.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Bank of Japan minutes turn hawkish: Most members believe a rate hike is needed soon, with a 70% probability of a hike in December
Minutes from the Bank of Japan show that several members believe a rate hike is needed in the near term, with a roughly 70% probability of an increase in December. Core inflation has met the target for the first time in 30 years, and the current policy rate stands at 1.25%.
Former Chainlink Product Marketing Director Michael Robinson joins Monad Foundation
Crypto prices
More
